Vestronidase alfa
Mepsevii (vestronidase alfa) is an enzyme pharmaceutical. Vestronidase alfa was first approved as Mepsevii on 2017-11-15. It has been approved in Europe to treat mucopolysaccharidosis VII.
| Trade Name | Mepsevii |
|---|---|
| Common Name | Vestronidase alfa |
| Indication | mucopolysaccharidosis vii |
| Drug Class | Enzymes; estrogens |
